Methyl 2-(3-azaspiro[5.5]undecan-9-yl)acetate

Catalog No.: 
ACVBDR204
CAS No.: 
1017623-70-9
Molecular Formula: 
C13H23NO2
Molecular Weight: 
225.33
Methyl 2-(3-azaspiro[5.5]undecan-9-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$967.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(3-azaspiro[5.5]undecan-9-yl)acetate
IUPAC Namemethyl 2-(3-azaspiro[5.5]undecan-9-yl)acetate
MDL No.MFCD26402792
Molecular FormulaC13H23NO2
Molecular Weight225.33
SMILESO=C(OC)CC(CC1)CCC21CCNCC2
InChI KeyJUOLQMDMNLPCKJ-UHFFFAOYSA-N
Synonym3-Azaspiro[5.5]undecane-9-acetic acid methyl ester;(3-Aza-spiro[5.5]undec-9-yl)-acetic acid methyl ester;Methyl 2-(3-azaspiro[5.5]Undecan-9-yl)acetate
CAS No.1017623-70-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVBDR204 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZITU658 route compound structure diagram
    ACZITU6581346229-41-1In Stock
  2. Then
  3. ACVBDR204 route product structure diagram
    ACVBDR2041017623-70-9
Inquiry

2. ACVBDR204 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXSEA531 route compound structure diagram
    ACXSEA531952480-32-9In Stock
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACVBDR204 route product structure diagram
    ACVBDR2041017623-70-9
Inquiry

3. ACVBDR204 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZITU658 route compound structure diagram
    ACZITU6581346229-41-1In Stock
  2. Then
  3. ACVBDR204 route product structure diagram
    ACVBDR2041017623-70-9
Inquiry

Comments (0)